Does dialysis modality influence the oxidative stress of uremic patients?

Kidney and Blood Pressure Research

Volumn 35, Issue 4, 2012, Pages 220-225

  Capusa, Cristina ^a   Stoian, Irina ^a   Rus, Elvira ^a   Lixandru, Dana ^a   Barbulescu, Carmen ^a   Mircescu, Gabriel ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Chronic kidney disease; Continuous ambulatory peritoneal dialysis; Extracellular antioxidant status; Hemodialysis; Lipid peroxidation; Oxidative stress

Indexed keywords

ALBUMIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; URIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSIS; FEMALE; HEMODIALYSIS; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RESIDUAL ANTIOXIDANT ACTIVITY; SPECTROPHOTOMETRY; TOTAL ANTIOXIDANT ACTIVITY;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UREMIA;

EID: 84855415756     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000331560     Document Type: Article

References (28)

1. Ward RA, McLeish KR: Oxidant stress in hemodialysis patients: What are the determining factors? Artif Organs 2003; 27: 230-236.
2. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538.
3. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thévenin M, Jaudon MC, et al: Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 1996; 21: 845-853.
4. Agalou S, Ahmed N, Dawnay A, Thornalley PJ: Removal of advanced glycation end products in clinical renal failure by peritoneal dialysis and haemodialysis. Biochem Soc Trans 2003; 31: 1394-1396.
5. Canaud B, Cristol J-P, Morena M, Leray-Moragues H, Bosc J-Y, Vaussenat F: Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif 1999; 17: 99-106.
6. Tarng DC, Chen TW, Huang T-P, Chen C-L, Liu T-Y, Wei YH: Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol 2002; 13: 1321-1330.
7. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG: Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003; 14: 415-424.
8. Ignace S, Fouque D, Arkouche W, Steghens J-P, Guebre-Egziabher F: Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients. Nephrol Dial Transplant 2009; 24: 1685-1689.
9. Mitrogianni Z, Barbouti A, Galaris D, Siamopoulos KC: Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients. Nephron Clin Pract 2009; 113:c234-c240.
10. Donate T, Herreros A, Martinez E, Martinez J, Andrés E, Cabezas A, et al: Protein oxidative stress in dialysis patients. Adv Perit Dial 2002; 18: 15-17.
11. Yonova D, Trendafilov I, Papazov V, Stanchev I, Zidarov R, Antonov S: Comparative study of oxidative stress in peritoneal dialysis and hemodialysis patients. Hippokratia 2004; 8: 170-172.
12. Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B: Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem 2002; 35: 269-273.
13. Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo LF, et al: Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artif Org 2005; 29: 67-72.
14. Covic A, Mircescu G, Gluhovschi G, Schiller A, Capusa C, Gusbeth-Tatomir P, et al, for the Romanian Society of Nephrology: Medical Practice Guidelines - Chronic Kidney Disease. Bucharest, Curtea Veche Publishing, 2007, p 19.
15. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: Malondialdehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-413.
16. Rice-Evans CA, Diplock AT, Symons MCR: Techniques in Free Radicals Research. Amsterdam, Elsevier, 1991, pp 207-234.
17. Miller NJ, Rice-Evans CA, Davies MJ, Gopinathan V, Milner A: A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407-412.
18. Miller NJ, Johnston JD, Collis CS, Rice-Evans CA: Serum total antioxidant activity after myocardial infarction. Ann Clin Biochem 1997; 34: 85-90.
19. Descamps-Latscha B, Drüeke T, Witko-Sarsat V: Dialysis-induced oxidative stress: Biological aspects, clinical consequences, and therapy. Semin Dial 2001; 14: 193-199.
20. Clermont G, Lecour S, Lahet J-J, Siohan P, Vergely C, Chevet D, et al: Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: A possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res 2000; 47: 618-623.
21. Ross EA, Koo LC, Moberly JB: Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1997; 30: 489-494.
22. Mekki K, Taleb W, Bouzidi N, Kaddous A, Bouchenak M: Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: A comparative study. Lipids Health Dis 2010; 9: 93.
23. Samouilidou EC, Grapsa EJ, Kakavas I, Lagouranis A, Agrogiannis B: Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol 2003; 35: 393-397.
24. Rysz J, Stolarek RA, Pedzik A, Nowicki M, Nowak D: Serum antioxidant capacity is preserved in peritoneal dialysis contrary to its robust depletion after hemodialysis and hemodiafiltration sessions. Ther Apher Dial 2010; 14: 209-217.
25. Kim SB, Yang WS, Min WK, Lee SK, Park JS: Reduced oxidative stress in hypoalbuminemic CAPD patients. Perit Dial Int 2000; 20: 290-294.
26. Ahmadpoor P, Eftekhar E, Nourooz-Zadeh J, Servat H, Makhdoomi K, Ghafari A: Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. Iran J Kidney Dis 2009; 3: 22-27.
27. Prior RL, Cao G: In vivo total antioxidant capacity: Comparison of different analytical methods. Free Radic Biol Med 1999; 27: 1173-1181.
28. Nguyen-Khoa T, Massy ZA, Witko-Sarsat V, Thévenin M, Touam M, Lambrey G, et al: Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Kidney Int 1999; 56: 747-775.